The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Bankole A. Johnson

Department of Psychiatry and Neurobehavioral Sciences

University of Virginia

Charlottesville

VA 22908-0623

USA

[email]@virginia.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22908-0623, USA. 2005 - 2011
  • South Texas Addiction Research and Technology Center, Department of Psychiatry, The University of Texas Health Science Center at San Antonio, 3939 Medical Drive, USA. 2005
  • Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. 2005

References

  1. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. Johnson, B.A., Ait-Daoud, N., Seneviratne, C., Roache, J.D., Javors, M.A., Wang, X.Q., Liu, L., Penberthy, J.K., DiClemente, C.C., Li, M.D. Am. J. Psychiatry (2011) [Pubmed]
  2. Medication treatment of different types of alcoholism. Johnson, B.A. Am. J. Psychiatry (2010) [Pubmed]
  3. Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients. Johnson, B.A., Ait-Daoud, N. Curr. Pharm. Des. (2010) [Pubmed]
  4. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Johnson, B.A., Javors, M.A., Roache, J.D., Seneviratne, C., Bergeson, S.E., Ait-Daoud, N., Dawes, M.A., Ma, J.Z. Prog. Neuropsychopharmacol. Biol. Psychiatry (2008) [Pubmed]
  5. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Johnson, B.A. Biochem. Pharmacol. (2008) [Pubmed]
  6. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Johnson, B.A., Rosenthal, N., Capece, J.A., Wiegand, F., Mao, L., Beyers, K., McKay, A., Ait-Daoud, N., Addolorato, G., Anton, R.F., Ciraulo, D.A., Kranzler, H.R., Mann, K., O'Malley, S.S., Swift, R.M. Arch. Intern. Med. (2008) [Pubmed]
  7. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. Johnson, B.A., Ait-Daoud, N., Elkashef, A.M., Smith, E.V., Kahn, R., Vocci, F., Li, S.H., Bloch, D.A. Int. J. Neuropsychopharmacol. (2008) [Pubmed]
  8. Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. Johnson, B.A., Wells, L.T., Roache, J.D., Wallace, C.L., Ait-Daoud, N., Dawes, M.A., Liu, L., Wang, X.Q., Javors, M.A. Prog. Neuropsychopharmacol. Biol. Psychiatry (2007) [Pubmed]
  9. Topiramate for treating alcohol dependence: a randomized controlled trial. Johnson, B.A., Rosenthal, N., Capece, J.A., Wiegand, F., Mao, L., Beyers, K., McKay, A., Ait-Daoud, N., Anton, R.F., Ciraulo, D.A., Kranzler, H.R., Mann, K., O'Malley, S.S., Swift, R.M. JAMA (2007) [Pubmed]
  10. Effects of acute topiramate dosing on methamphetamine-induced subjective mood. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wells, L.T., Wallace, C.L., Dawes, M.A., Liu, L., Wang, X.Q. Int. J. Neuropsychopharmacol. (2007) [Pubmed]
  11. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wells, L.T., Wallace, C.L., Dawes, M.A., Liu, L., Wang, X.Q. Prog. Neuropsychopharmacol. Biol. Psychiatry (2007) [Pubmed]
  12. A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence. Johnson, B.A. Expert. Opin. Pharmacother (2006) [Pubmed]
  13. Understanding and treating alcohol dependence. Johnson, B.A., Koob, G.F., Schuckit, M.A., Mason, B.J., Ait-Daoud, N. Alcohol. Clin. Exp. Res. (2006) [Pubmed]
  14. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Javors, M.A., Harrison, J.M., Elkashef, A., Mojsiak, J., Li, S.H., Bloch, D.A. Drug. Alcohol. Depend (2006) [Pubmed]
  15. Pills for speedballing or cocaine dependence. Johnson, B.A. Lancet (2006) [Pubmed]
  16. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals. Johnson, B.A., Javors, M.A., Lam, Y.W., Wells, L.T., Tiouririne, M., Roache, J.D., Ait-Daoud, N., Lawson, K. Prog. Neuropsychopharmacol. Biol. Psychiatry (2005) [Pubmed]
  17. Safety and efficacy of GABAergic medications for treating alcoholism. Johnson, B.A., Swift, R.M., Addolorato, G., Ciraulo, D.A., Myrick, H. Alcohol. Clin. Exp. Res. (2005) [Pubmed]
  18. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. Johnson, B.A., Dawes, M.A., Roache, J.D., Wells, L.T., Ait-Daoud, N., Mauldin, J.B., Wang, Y., Lancaster, J.L., Fox, P.T. J. Cereb. Blood Flow Metab. (2005) [Pubmed]
  19. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wallace, C., Wells, L., Dawes, M., Wang, Y. Int. J. Neuropsychopharmacol. (2005) [Pubmed]
  20. Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wallace, C.L., Wells, L.T., Wang, Y., Dawes, M.A. Int. J. Neuropsychopharmacol. (2005) [Pubmed]
  21. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial. Johnson, B.A., Ait-Daoud, N., Akhtar, F.Z., Javors, M.A. Arch. Intern. Med. (2005) [Pubmed]
  22. Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry. Johnson, B.A., Mann, K., Willenbring, M.L., Litten, R.Z., Swift, R.M., Lesch, O.M., Berglund, M. Alcohol. Clin. Exp. Res. (2005) [Pubmed]
  23. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. Johnson, B.A. CNS. Drugs (2005) [Pubmed]
  24. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. Johnson, B.A., Ait-Daoud, N., Roache, J.D. J. Stud. Alcohol. Suppl (2005) [Pubmed]
 
WikiGenes - Universities